Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP401160.RAI0kXhfoBqpFo_mH0a50qMIbIyoN3nodknf2kyMUiuY0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP401160.RAI0kXhfoBqpFo_mH0a50qMIbIyoN3nodknf2kyMUiuY0130_assertion type Assertion NP401160.RAI0kXhfoBqpFo_mH0a50qMIbIyoN3nodknf2kyMUiuY0130_head.
- NP401160.RAI0kXhfoBqpFo_mH0a50qMIbIyoN3nodknf2kyMUiuY0130_assertion description "[A single blind, randomized, placebo-controlled, single-center phase I clinical trial of a CD8(+) T-cell peptide epitope vaccine against infectious mononucleosis was conducted with 14 HLA B*0801-positive, Epstein-Barr virus (EBV)-seronegative adults.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP401160.RAI0kXhfoBqpFo_mH0a50qMIbIyoN3nodknf2kyMUiuY0130_provenance.
- NP401160.RAI0kXhfoBqpFo_mH0a50qMIbIyoN3nodknf2kyMUiuY0130_assertion evidence source_evidence_literature NP401160.RAI0kXhfoBqpFo_mH0a50qMIbIyoN3nodknf2kyMUiuY0130_provenance.
- NP401160.RAI0kXhfoBqpFo_mH0a50qMIbIyoN3nodknf2kyMUiuY0130_assertion SIO_000772 18032491 NP401160.RAI0kXhfoBqpFo_mH0a50qMIbIyoN3nodknf2kyMUiuY0130_provenance.
- NP401160.RAI0kXhfoBqpFo_mH0a50qMIbIyoN3nodknf2kyMUiuY0130_assertion wasDerivedFrom befree-20140225 NP401160.RAI0kXhfoBqpFo_mH0a50qMIbIyoN3nodknf2kyMUiuY0130_provenance.
- NP401160.RAI0kXhfoBqpFo_mH0a50qMIbIyoN3nodknf2kyMUiuY0130_assertion wasGeneratedBy ECO_0000203 NP401160.RAI0kXhfoBqpFo_mH0a50qMIbIyoN3nodknf2kyMUiuY0130_provenance.